The medical prescription issued in your own country is recognized in all the other countries of the European Union.

The medicines and medical devices, which can be commercialized in Italy, and have been prescribed in another member State of the European Union shall be distributed in the territory in accordance to the Italian national laws.

The prescription will not be recognized if there are justified doubts about the possible side effects of medicines or medical devices, or about the authenticity, content, comprehensibility of an individual prescription, or for ethical reasons too.

Recognition does not apply  to medicinal products subject to special medical prescription as stated in the Article 71(2) of Directive 2001/83/EC (implemented in Italy by Legislative Decree no. April 26, 2006, n. 219), e. g.  any medicines containing substances classified as psychotropic or narcotic.

To facilitate recognition of the prescription in another EU country, the following data needs to be included:

Identification of the patient

  • Surname(s)
  • First name(s) (written out in full, i.e. no initials)
  • Date of Birth

Authentication of the prescription

  • Issue date

Identification of the prescribing health professional

  • Surname(s)
  • First name(s) (written out in full, i.e. no initials)
  • Professional qualification
  • Details for direct contact (email and telephone or fax, the latter both with international prefix)
  • Work address (including the name of the relevant Member State)
  • Signature (written or digital, depending on the medium chosen for issuing the prescription)

Identification of the prescribed product, where applicable

  • ‘Common name’ as defined by Article 1 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use or the brand name if:
    • the prescribed product is a biological medicinal product, as defined in point of Annex I (Part I) to Directive 2001/83
    • the prescribing health professional deems it medically necessary; in that case the prescription shall shortly state the reasons justifying the use of the brand name
  • Pharmaceutical formulation (tablet, solution, etc.)
  • Quantity
  • Strength, as defined in Article 1 of Directive 2001/83/EC
  • Dosage regimen

Patients enrolled in the health care system of another EU country, who have purchased a medicine or medical device in Italy, can request a refund to the competent health institution.
The refundable about is normally equal to the cost that the health care system would have incurred if the drug or medical device would have been provided in the country of affiliation.
It is recommended to safe keep the prescription and the receipt or invoice payment, which may be required to obtain a refund.

Data di pubblicazione: 4 aprile 2014, ultimo aggiornamento 16 dicembre 2014

Pubblicazioni   |   Opuscoli e poster   |   Normativa   |   Home page dell'area tematica Torna alla home page dell'area